Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Paired Trades and Hedging Strategies -- Ignore unavailable to you. Want to Upgrade?

To: Sam Citron who wrote (27)	11/16/2004 5:06:53 PM
From: Biomaven	Read Replies (2) \| Respond to of 136

Sam, The AMD/INTC trade has indeed worked out better than I could have hoped. I'm keeping it in place for now. With Intel still at 20X AMD's market cap, there's still room to move. In your biotech example, both the puts and calls are very expensive. Thus I don't think you are going to get rich playing options unless you have a good idea on the outcome of the trial. Where the implied volatility is not so extreme, sometimes a straddle or strangle can be a good play. Mostly biotechs tend not to creep up in anticipation of results unless there has been a leak. There are indeed some sites that track unusual options activity. I also can't recall specific names though. It's noteworthy that MRK puts soared just before the Vioxx news. Ivolatility.com does track unusually high implied volatilities if I recall correctly - I haven't looked in a while, and the site has changed. Peter